Alzamend Neuro's market cap is currently ―. The company's EPS TTM is $-1.87; its P/E ratio is -0.40; Alzamend Neuro is scheduled to report earnings on March 16, 2023, and the estimated EPS forecast is $-0.60. See an overview of income statement, balance sheet, and cash flow financials.

	Jan 24	Oct 23	Jul 23	Apr 23	Jan 23
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -2.66M	$ -2.90M	$ -3.53M	-	$ -5.42M
EBITDA	$ -2.65M	$ -2.89M	$ -3.51M	-	$ 0.00
Net Income Common Stockholders	$ -2.66M	$ -2.91M	$ -3.53M	-	$ -5.43M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 282.87K	$ 200.08K	$ 1.70M	$ 5.14M	$ 7.38M
Total Assets	$ 782.64K	$ 983.60K	$ 2.63M	$ 5.92M	$ 8.50M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -282.87K	$ -200.08K	$ -1.70M	$ -5.14M	$ -7.38M
Total Liabilities	$ 4.57M	$ 3.67M	$ 2.74M	$ 2.87M	$ 2.64M
Stockholders Equity	$ -4.26M	$ -2.68M	$ -112.88K	$ 3.05M	$ 5.86M
Cash Flow	-
Free Cash Flow	$ -2.03M	$ -1.51M	$ -3.45M	$ -2.24M	-
Operating Cash Flow	$ -2.03M	$ -1.51M	$ -3.30M	$ -2.24M	-
Investing Cash Flow	-	-	$ -147.24K	-	-
Financing Cash Flow	$ 2.11M	$ 18.09K	-	$ 200.00	-

Currency in USD

Alzamend Neuro Earnings and Revenue History

Income Statement >

Alzamend Neuro Debt to Assets

Balance Sheet >

Alzamend Neuro Cash Flow

Cash Flow >

Alzamend Neuro Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing